Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial).
Robijns J, Lodewijckx J, Claes S, Van Bever L, Pannekoeke L, Censabella S, Bussé L, Colson D, Kaminski I, Broux V, Puts S, Vanmechelen S, Timmermans A, Noé L, Bulens P, Govers M, Maes A, Mebis J. Robijns J, et al. Among authors: maes a. Radiother Oncol. 2021 May;158:268-275. doi: 10.1016/j.radonc.2021.03.002. Epub 2021 Mar 10. Radiother Oncol. 2021. PMID: 33711412 Free article. Clinical Trial.
Response to the Letter to the editor by Donnelly et al. regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)".
Robijns J, Lodewijckx J, Claes S, Van Bever L, Pannekoeke L, Censabella S, Bussé L, Colson D, Kaminski I, Broux V, Puts S, Vanmechelen S, Timmermans A, Noé L, Bulens P, Govers M, Maes A, Mebis J. Robijns J, et al. Among authors: maes a. Radiother Oncol. 2021 Aug;161:255-256. doi: 10.1016/j.radonc.2021.06.009. Epub 2021 Jun 10. Radiother Oncol. 2021. PMID: 34119590 No abstract available.
Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by Baiocchi et al.
Robijns J, Lodewijckx J, Claes S, Van Bever L, Pannekoeke L, Censabella S, Bussé L, Colson D, Kaminski I, Broux V, Puts S, Vanmechelen S, Timmermans A, Noé L, Bulens P, Govers M, Maes A, Mebis J. Robijns J, et al. Among authors: maes a. Radiother Oncol. 2021 Oct;163:242-243. doi: 10.1016/j.radonc.2021.07.002. Epub 2021 Jul 16. Radiother Oncol. 2021. PMID: 34274395 No abstract available.
Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole-breast irradiation (LABRA trial).
Robijns J, Lodewijckx J, Puts S, Vanmechelen S, Van Bever L, Claes S, Pannekoeke L, Timmermans A, Noé L, Govers M, Van de Werf E, Maes A, Bulens P, Mebis J. Robijns J, et al. Among authors: maes a. Lasers Surg Med. 2022 Mar;54(3):374-383. doi: 10.1002/lsm.23475. Epub 2021 Sep 4. Lasers Surg Med. 2022. PMID: 34481420 Clinical Trial.
Prevention of acute radiodermatitis by photobiomodulation: A randomized, placebo-controlled trial in breast cancer patients (TRANSDERMIS trial).
Robijns J, Censabella S, Claes S, Pannekoeke L, Bussé L, Colson D, Kaminski I, Bulens P, Maes A, Noé L, Brosens M, Timmermans A, Lambrichts I, Somers V, Mebis J. Robijns J, et al. Among authors: maes a. Lasers Surg Med. 2018 Feb 10. doi: 10.1002/lsm.22804. Online ahead of print. Lasers Surg Med. 2018. PMID: 29427390
Biophysical skin measurements to evaluate the effectiveness of photobiomodulation therapy in the prevention of acute radiation dermatitis in breast cancer patients.
Robijns J, Censabella S, Claes S, Pannekoeke L, Bussé L, Colson D, Kaminski I, Lodewijckx J, Bulens P, Maes A, Noé L, Brosens M, Timmermans A, Lambrichts I, Somers V, Mebis J. Robijns J, et al. Among authors: maes a. Support Care Cancer. 2019 Apr;27(4):1245-1254. doi: 10.1007/s00520-018-4487-4. Epub 2018 Oct 1. Support Care Cancer. 2019. PMID: 30270415 Clinical Trial.
Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by He et al.
Robijns J, Lodewijckx J, Claes S, Van Bever L, Pannekoeke L, Censabella S, Bussé L, Colson D, Kaminski I, Broux V, Puts S, Vanmechelen S, Timmermans A, Noé L, Bulens P, Govers M, Maes A, Mebis J. Robijns J, et al. Among authors: maes a. Radiother Oncol. 2022 Apr;169:143-144. doi: 10.1016/j.radonc.2022.01.002. Epub 2022 Jan 19. Radiother Oncol. 2022. PMID: 35065145 No abstract available.
365 results